National Health Investors (NYSE:NHI) Lowered to “Underperform” at Mizuho


Share on StockTwits

Mizuho lowered shares of National Health Investors (NYSE:NHI) from a neutral rating to an underperform rating in a research note issued to investors on Wednesday morning, Anlyst Ratings reports. The firm currently has $55.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $56.00.

NHI has been the topic of a number of other reports. Zacks Investment Research upgraded shares of National Health Investors from a hold rating to a buy rating and set a $75.00 target price on the stock in a research note on Tuesday. KeyCorp upgraded shares of National Health Investors from an underweight rating to a sector weight rating in a research note on Monday, December 14th. Berenberg Bank downgraded shares of National Health Investors from a buy rating to a hold rating in a research note on Wednesday, December 2nd. Finally, BMO Capital Markets downgraded shares of National Health Investors from a market perform rating to an underperform rating and set a $68.00 price objective on the stock. in a research note on Thursday, January 7th. Two research analysts have rated the stock with a sell rating and seven have given a hold rating to the company’s stock. National Health Investors presently has a consensus rating of Hold and a consensus price target of $65.63.

NHI stock traded up $0.64 during mid-day trading on Wednesday, reaching $67.56. The company had a trading volume of 2,860 shares, compared to its average volume of 321,755. The company has a debt-to-equity ratio of 1.02, a current ratio of 13.13 and a quick ratio of 13.13. The company has a market capitalization of $3.02 billion, a PE ratio of 15.71 and a beta of 0.85. The firm has a 50 day moving average of $67.72 and a 200 day moving average of $62.94. National Health Investors has a 12 month low of $31.37 and a 12 month high of $91.12.

National Health Investors (NYSE:NHI) last issued its earnings results on Monday, November 9th. The real estate investment trust reported $0.95 EPS for the quarter, missing the Zacks’ consensus estimate of $1.43 by ($0.48). The company had revenue of $84.30 million during the quarter, compared to the consensus estimate of $82.87 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. National Health Investors’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.42 earnings per share. Analysts anticipate that National Health Investors will post 5.63 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 31st will be issued a $1.102 dividend. The ex-dividend date is Wednesday, December 30th. This represents a $4.41 dividend on an annualized basis and a dividend yield of 6.52%. National Health Investors’s dividend payout ratio is currently 80.18%.

In other news, Director Robert G. Adams acquired 2,000 shares of the business’s stock in a transaction on Monday, December 14th. The stock was bought at an average price of $67.75 per share, with a total value of $135,500.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert G. Adams acquired 1,000 shares of the business’s stock in a transaction on Tuesday, November 17th. The stock was purchased at an average cost of $66.45 per share, with a total value of $66,450.00. The disclosure for this purchase can be found here. Company insiders own 5.74% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in NHI. Charles Schwab Investment Management Inc. grew its stake in National Health Investors by 52.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 516,950 shares of the real estate investment trust’s stock valued at $31,157,000 after acquiring an additional 178,095 shares during the last quarter. Hamlin Capital Management LLC raised its position in National Health Investors by 7.8% in the third quarter. Hamlin Capital Management LLC now owns 928,437 shares of the real estate investment trust’s stock worth $55,957,000 after acquiring an additional 66,864 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in National Health Investors by 83.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 132,714 shares of the real estate investment trust’s stock worth $7,999,000 after acquiring an additional 60,495 shares in the last quarter. Public Employees Retirement System of Ohio raised its position in National Health Investors by 586.0% in the second quarter. Public Employees Retirement System of Ohio now owns 52,777 shares of the real estate investment trust’s stock worth $3,205,000 after acquiring an additional 45,083 shares in the last quarter. Finally, UBS Asset Management Americas Inc. raised its position in National Health Investors by 18.8% in the third quarter. UBS Asset Management Americas Inc. now owns 230,276 shares of the real estate investment trust’s stock worth $13,879,000 after acquiring an additional 36,485 shares in the last quarter. Institutional investors and hedge funds own 62.41% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Debt-To-Equity Ratio

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.